2 options
Staff report on Sanofi's strategic use of third parties to influence the FDA / prepared by the staff of the Committee on Finance, United States Senate.
- Format:
- Book
- Government document
- Series:
- S. prt. ; 111-20.
- S. prt. ; 112-20
- Language:
- English
- Subjects (All):
- Sanofi aventis (Firm)--Corrupt practices.
- Sanofi aventis (Firm).
- United States. Food and Drug Administration--Management.
- United States.
- United States. Food and Drug Administration.
- Drug approval--Corrupt practices--United States.
- Drug approval.
- Anticoagulants (Medicine)--Government policy--United States.
- Anticoagulants (Medicine).
- Generic drugs--Government policy--United States.
- Generic drugs.
- Corruption.
- Generic drugs--Government policy.
- Management.
- Genre:
- legislative records.
- Legislative materials
- Legislative materials.
- Physical Description:
- 1 online resource (iii, 177 pages).
- Place of Publication:
- Washington : U.S. G.P.O., 2011.
- Notes:
- Includes bibliographical references.
- Electronic reproduction. [Place of publication not identified] : HathiTrust Digital Library, 2011.
- Other Format:
- Print version: Staff report on Sanofi's strategic use of third parties to influence the FDA
- Microfiche: Staff report on Sanofi's strategic use of third parties to influence the FDA
- OCLC:
- 741958525
- Access Restriction:
- Use copy Restrictions unspecified
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.